FDA approves Adlyxin to treat type 2 diabetes - FDA Press Releases

The U.S. Food and Drug Administration approved Adlyxin (lixisenatide), a once-daily injection to improve glycemic control (blood sugar levels), along with diet and exercise, in adults with type 2 diabetes.

from Food and Drug Administration--Press Releases http://ift.tt/2aj8NKq
via IFTTT